SURG-30. DOES LEVETIRACETAM ACT AS A TEMOZOLOMIDE CHEMOSENSITIZER IN PATIENTS WITH GLIOBLASTOMA?

BACKGROUND: In a recent study, patients with glioblastoma (GBM) who administered Levetiracetam (LEV) during chemoradiotherapy were reported to have survival benefit. However, the effect of LEV on survival of glioblastoma patients is not well known. METHODS: From 2004 to 2016, 340 patients with surgi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Roh, Tae-Hoon, Kim, Se-Hyuk, Kang, Seok-Gu, Kim, Eui Hyun, Cho, Jaeho, Suh, Chang Ok, Kim, Se Hoon, Chang, Jong Hee
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692441/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.984
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars